Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Skinfuse is a comprehensive 90-day post-procedure skincare protocol developed by Crown Aesthetics (formerly Bellus Medical) specifically for use following microneedling treatments. The system is designed to optimize skin recovery and clinical outcomes by providing essential nutrients while omitting ingredients that could impair the healing process. The protocol consists of several targeted products, including LIFT HG (wound healing), PURIFY (cleanser), RESCUE Calming Complex (soothing), RECLAIM Hydrating Support (barrier repair), SURGE 1 Collagen Boost (vitamin-rich remodeling), FORTIFY (anti-inflammatory), and SHIELD (sunscreen). Its mechanism of action focuses on resealing the skin barrier, preventing trans-epidermal water loss (TEWL), and supporting collagen and elastin remodeling through the delivery of vitamins A and C, copper peptides, and minerals like magnesium and zinc.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Skinfuse.